PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹253.37bn
- IN₹88.69bn
India's Piramal Pharma surges on Q2 profit, analysts' positive view
Brief: Piramal Pharma Limited Announces Consolidated Results For Q2 And H1 FY2024
India's Piramal Pharma up on launching in-vitro biology capabilities
Brief: Piramal Pharma Says Piramal Pharma Solutions Launches In-Vitro Biology Capabilities At Ahmedabad Discovery Services Site
Brief: Piramal Pharma Says US FDA Conducted Gmp Inspection Of Co's Bethlehem Facility From Sept 18 To Sept 27
Brief: Piramal Pharma Says Voluntary Liquidation Of Unit Piramal Pharma Japan GK Approved By Authority
Brief: India's Piramal Pharma Ltd June-Quarter Consol Net Loss After Tax Narrows
India's Piramal Pharma jumps as Jefferies eyes margin growth in FY24
Brief: Plus Therapeutics Inc Says Announced An Expansion Of Its Collaboration With Piramal Pharma Solutions
India's Piramal Pharma up after FDA closes inspection of US plant
Brief: Piramal Pharma Says Successful Closure Of US FDA Inspection At Co Manufacturing Facility Located At Sellersville, USA
India's Piramal Pharma rises on successful completion of USFDA probe
India's Piramal Pharma slides 13% in seven days to record low
India's Piramal Pharma sees best day in over 2 weeks
Brief: Piramal Pharma Us FDA Inspection Has Now Been Closed, Issued Establishment Inspection Report
Brief: Piramal Pharma Us FDA Conducted Pre-Approval Inspection And Good Manufacturing Practices Inspection Of Lexington Facility
Jefferies initiates Piramal Pharma at 'buy' rating
India's Piramal Pharma up on anti-dumping probe on Vitamin A-Palmitate imports
Brief: Piramal Pharma Limited Lists On BSE And NSE